Our Publications

Sebastian Palmqvist et al.

Blood Biomarkers to Detect Alzheimer Disease in Primary Care and Secondary Care

JAMA NEUROLOGY

|

July 2024

|

Lianlian Du et al.

Longitudinal plasma phosphorylated-tau217 and other related biomarkers in a non-demented Alzheimer’s risk-enhanced sample

Alzheimer’s & Dementia

|

July 2024

|

Phuong Thuy Nguyen Ho et al.

Sleep, 24-Hour Activity Rhythms, and Subsequent Amyloid-ß Pathology

Jama Neurology

|

July 2024

|

Hanna Huber et al.

Biomarkers of Alzheimer’s disease and neurodegeneration in dried bloodspots—A new collection method for remote settings

Alzheimer’s & Dementia

|

Jan 2024

|

Sylvain Lehmann et al.

Clinical value of plasma ALZpath pTau217 immunoassay in the assessment of mild cognitive impairment

J Neurol Neurosurg Psychiatry

|

Jan 2024

|

Nicholas Ashton et al.

Diagnostic accuracy of the plasma ALZpath pTau217 immunoassay to identify Alzheimer’s disease pathology.

Jama Network

|

Jan 2024

|

Mariam Gouda et al.

Plasma phosphorylated tau217 levels are highly stable under common pre-analytical sample handling procedures

Alzheimer’s & Dementia

|

Dec 2023

|

Zhenxu Xiao et al.

Plasma p-tau217, p-tau181, and NfL as early indicators of dementia risk in a community cohort: The Shanghai Aging Study

Alzheimer’s & Dementia

|

Dec 2023

|

Wagner Brum et al.

Biological variation estimates of Alzheimer’s disease plasma biomarkers in healthy individuals.

Neurology

|

Nov 2023

|

Jean Ikanga et al.

Sensitivity of the African Neuropsychology Battery Memory Subtests and Learning Slopes in Discriminating APOE 4 and Amyloid Pathology in Adult Individuals in the Democratic Republic of Congo.

medRxiv

|

Oct 2023

|

Joseph Therriault et al.

Comparison of Two Plasma P-Tau217 Assays to Detect and Monitor Alzheimer’s Pathology.

The Lancet

|

Sept 2023

|